Precision Care Medicine students work with clinical faculty at Johns Hopkins Medicine to learn how to use machine learning ...

Scientists at Northwestern University have developed a new approach that directly combats the progression of ...

Neurosense Therapeutics said it's producing its ALS therapy PrimeC at a commercial scale as it prepares for potential ...

The treatment traps and neutralizes misfolded proteins to stop the progression of Alzheimer's disease and other neurodegenerative disorders.

Athira Pharma (ATHA) announced that the Company will present data from a Phase 1 clinical trial of ATH-1105 in healthy volunteers at the 4th Annual ALS drug Development Summit taking place from May 12 ...

Apple is reportedly working with brain-computer interface (BCI) company Synchron to develop technology that allows users to ...

Results of the MIROCALS (Modifying Immune Responses and Outcomes in ALS) clinical trial are published in The Lancet. This is ...

Apple is developing brain-computer interface technology to allow users to control devices like iPhones using brain signals.

Apple is making strides towards a future where people control their iPhones with thoughts, using brain implants, according to ...

Apple has partnered with Synchron, a neurotechnology startup that has developed the Stentrode, an implantable brain-computer ...